AF
RCUS icon

Allworth Financial’s Arcus Biosciences RCUS Stock Holding History

Allworth Financial’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.88K Sell
61
-19
-24% -$470 ﹤0.01% 4533
2026
Q1 		$1.73K Buy
80
+53
+196% +$1.15K ﹤0.01% 4388
2025
Q4 		$644 Buy
27
+23
+575% +$469 ﹤0.01% 4473
2025
Q3 		$55 Buy
+4
New +$42 ﹤0.01% 4738
2023
Q4 		– Sell
-53
Closed -$952 – 3589
2023
Q3 		$952 Hold
53
– – ﹤0.01% 2868
2023
Q2 		$1.08K Hold
53
– – ﹤0.01% 2706
2023
Q1 		$967 Buy
53
+23
+77% +$440 ﹤0.01% 2682
2022
Q4 		$620 Hold
30
– – ﹤0.01% 2578
2022
Q3 		$1K Buy
+30
New +$793 ﹤0.01% 2474

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Allworth Financial's RCUS Position: Q2 2026 in Review

Allworth Financial reduced its Arcus Biosciences (RCUS) stake by 24% in Q2 2026, selling an estimated $470 and leaving 61 shares worth $1.88K. The position accounts for ﹤0.01% of the portfolio, ranked #4533.

Allworth Financial first reported a position in RCUS in Q3 2022 and has held it in 9 quarters since. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Allworth Financial held 61 shares of Arcus Biosciences worth $1.88K as of Q2 2026.
  • Allworth Financial sold 19 Arcus Biosciences shares in Q2 2026, an estimated $470.
  • Arcus Biosciences made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4533 holding.
  • Allworth Financial first reported a position in Arcus Biosciences in Q3 2022 and has held it in 9 quarters since.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.